Arkolith/Insider Trading/PBYI/Form 4

Auerbach Alan H

President and CEO, Director, 10% OwnerPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jul 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$62K
Net Open-Market Flow
-$62K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2024Sell(S)19K$3.27$62K7.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-022061) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML